Phaarmasia Ltd
Phaarmasia Ltd (523620): company summary
Phaarmasia Ltd (523620) is a micro-cap Healthcare company valued at ₹58 crore operating in Pharmaceuticals on the NSE and BSE.
Phaarmasia Ltd (523620) is a micro-cap Healthcare company valued at ₹58 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 20.5% a year over three years. Return on equity is 12.8%.
- Valuation multiples
- The stock trades at 3.3 times earnings, a discount to the Healthcare median of 32.5, 3.26 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.0), but held back by quality (0.7). Scored on 4 of 5 measures.
DocStoX score
Medium confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Low leverage — D/E 0.05
- Undemanding at 3× earnings
- Revenue compounding 24% a year
- Loss-making in some of the last 5 years
- Quality is weak (0.7/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Phaarmasia Ltd’s valuation
Free deep-dive tools · no sign-up
Phaarmasia Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Phaarmasia Ltd with the ratios and calculators DocStoX uses in its analysis.

